Signal transducers and activators of transcription (STATs) gene polymorphisms related with susceptibility to rheumatic heart disease in north Indian population

Immunology Letters

Volumn 161, Issue 1, 2014, Pages 100-105

  Gupta, Usha ^a,b   Mir, Snober S ^b   Srivastava, Apurva ^a   Garg, Naveen ^a   Agarwal, Surendra K ^a   Pande, Shantanu ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INTEGRAL UNIVERSITY   (India)

Author keywords

Indian population; RHD; STAT3; STAT5b

Indexed keywords

STAT3 PROTEIN; STAT5B PROTEIN; STAT PROTEIN;

ADOLESCENT; ADULT; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; INDIAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; STAT3 GENE; STAT5B GENE; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE STENOSIS; AGE; ALLELE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; AGE FACTORS; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RHEUMATIC HEART DISEASE; SEX FACTORS; STAT TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84901987726     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.04.015     Document Type: Article

References (36)

1. Rajamannan N.M., Antonini-Canterin F., Moura L., Zamorano J.L., Rosenhek R.A., Best P.J., et al. Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive. Indian Heart J 2009, 61:14-23.
2. Roberts K., Colquhoun S., Steer A., Remenyi B., Carapetis J. Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol 2013, 10:49-58.
3. Chopra P., Bhatia M.L. Chronic rheumatic heart disease in India: a reappraisal of pathologic changes. J Heart Valve Dis 1992, 1:92-101.
4. Chou H.T., Chen C.H., Tsai C.H., Tsai F.J. Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 2004, 148:181-186.
5. Rehman S., Akhtar N., Saba N., Munir S., Ahmed W., Mohyuddin A., et al. A study on the association of TNF-alpha(-308), IL-6(-174), IL-10(-1082) and IL-1Ra(VNTR) gene polymorphisms with rheumatic heart disease in Pakistani patients. Cytokine 2013, 61:527-531.
6. Settin A., Abdel-Hady H., El-Baz R., Saber I. Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 2007, 28:363-371.
7. Guilherme L., Cury P., Demarchi L.M., Coelho V., Abel L., Lopez A.P., et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004, 165:1583-1591.
8. Duzgun N., Duman T., Haydardedeoglu F.E., Tutkak H. Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart disease. Tissue Antigens 2009, 74:539-542.
9. Berdeli A., Celik H.A., Ozyurek R., Dogrusoz B., Aydin H.H. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med (Berl) 2005, 83:535-541.
10. Ramasawmy R., Spina G.S., Fae K.C., Pereira A.C., Nisihara R., Messias Reason I.J., et al. Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin Vaccine Immunol 2008, 15:932-936.
11. Bao L., Zhang H., Chan L.S. The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis. JAKSTAT 2013, 2:e24137.
12. Ferguson L.R., Han D.Y., Fraser A.G., Huebner C., Lam W.J., Morgan A.R., et al. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population. Mutat Res 2010, 690:108-115.
13. Ivashkiv L.B., Hu X. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective. Arthritis Rheum 2003, 48:2092-2096.
14. Zhang L., Kao W.H., Berthier-Schaad Y., Liu Y., Plantinga L., Jaar B.G., et al. Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular disease in dialysis patients. J Am Soc Nephrol 2006, 17:2285-2292.
15. Peng Y., Zhou B., Wang Y., Chen Y., Li H., Song Y., et al. Association between polymorphisms in the signal transducer and activator of transcription and dilated cardiomyopathy in the Chinese Han population. Mol Cell Biochem 2012, 360:197-203.
16. Rickham P.P. Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki. Br Med J 1964, 2:177.
17. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
18. Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
19. Jonathan M. Carlson DHaGS. Estimating false discovery rates for contingency tables. Microsoft Research MSR-TR-2009-53 2009.
20. Lee P.H., Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 2008, 36:D820-D824.
21. Yuan H.Y., Chiou J.J., Tseng W.H., Liu C.H., Liu C.K., Lin Y.J., et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006, 34:W635-W641.
22. Mishra T. Acute rheumatic fever and rheumatic heart disease: current scenario. J Indian Acad Clin Med 2007, 8:324-330.
23. Guilherme L., Ramasawmy R., Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol 2007, 66:199-207.
24. Kreil S., Waghorn K., Ernst T., Chase A., White H., Hehlmann R., et al. A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon alpha. Haematologica 2010, 95:148-152.
25. Ito N., Eto M., Nakamura E., Takahashi A., Tsukamoto T., Toma H., et al. STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma. J Clin Oncol 2007, 25:2785-2791.
26. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 2008, 120:172-185.
27. Fischer P., Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol 2007, 102:279-297.
28. Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
29. Jacoby J.J., Kalinowski A., Liu M.G., Zhang S.S., Gao Q., Chai G.X., et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci U S A 2003, 100:12929-12934.
30. Yamauchi-Takihara K. gp130-mediated pathway and heart failure. Future Cardiol 2008, 4:427-437.
31. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., Kaminski K., Schaefer A., Schieffer B., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 2004, 95:187-195.
32. Hilfiker-Kleiner D., Hilfiker A., Drexler H. Many good reasons to have STAT3 in the heart. Pharmacol Ther 2005, 107:131-137.
33. Negoro S., Kunisada K., Fujio Y., Funamoto M., Darville M.I., Eizirik D.L., et al. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 2001, 104:979-981.
34. Hilfiker-Kleiner D., Shukla P., Klein G., Schaefer A., Stapel B., Hoch M., et al. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation 2010, 122:145-155.
35. Torre-Amione G., Kapadia S., Lee J., Durand J.B., Bies R.D., Young J.B., et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996, 93:704-711.
36. Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 1996, 11:302-309.